[ad_1]
Broken emails
Receive alerts and special reports. News and stories that matter, delivered in the morning on weekdays.
For Coca-Cola, the largest soft drink company in the world, considering developing a cannabis infused beverage shows how exciting it is for the potential health benefits of cannabidiol or CBD.
However, all the buzz surrounding the CBD, a compound derived from marijuana that does not end up in the user, is not yet supported by research.
On Monday, a report by BNN Bloomberg, a Canadian press service, claimed that Coke and Aurora Cannabis, a Canadian cannabis producer, were in "serious talks" to develop such beverages, a move attributed to unidentified sources.
Coca-Cola called the report "speculative" and said in a statement that it "was closely monitoring the growth of non-psychoactive CBD" as an ingredient in wellness drinks.
While the market for CBD-based products is "changing rapidly", as the beverage company has described, there have not been enough scientific studies to determine the overall health benefits of the CBD.
A handful of new drinks that infuse CBD with alcohol, coffee and juice tout their health benefits. Vybes, who says that his product "is not a drink, it's a feeling – a way to a more balanced and anchored life", is a CBD-based drink that claims to regulate the body's health. anxiety, sleep, mood and memory. The ingredient is also used in many beauty products, shampoos and chocolates.
But there are many more personal stories and anecdotes about what cannabidiol does for mental health or to relieve pain – two of the most common claims about CBD – that the scientific evidence .
Most studies on CBD have focused on his treatment of epilepsy. The Food and Drug Administration has approved Epidiolex, the first prescription cannabidiol-based drug used to treat rare forms of epilepsy earlier this year. The World Health Organization (WHO) released a report last year that also affirmed the benefits of the CBD for epilepsy, but said more research is needed to determine its potential effectiveness in other areas , such as drug addiction.
Research on CBD in the United States is difficult because CBD is derived from marijuana, a drug classified by the Drug Enforcement Administration as Schedule 1, with no medical benefits and a high potential for violence.
Source link
